XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:      
Net loss   $ (1,714,434) $ (168,458)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation   5,947  
Share-based compensation expense   82,945 1,397
Change in fair market value of derivative liabilities $ (3,069,000) 867,000  
Non-cash interest expense   39,138 6,358
Change in fair market value of warrant liability (42,346) 4,769  
Changes in assets and liabilities:      
Prepaid expenses and other current assets   (457,453) (3,200)
Accounts payable and accrued expenses   266,528 3,188
Deferred grant income   251,810  
Accrued interest on convertible promissory notes   55,598 54,071
Net cash used in operating activities   (598,152) (106,644)
Cash flows from investing activities:      
Purchase of fixed assets   (97,541)  
Net cash from (used in) investing activities   (97,541)  
Cash flows from financing activities:      
Proceeds from convertible promissory notes     1,190,000
Proceeds from subscription receivable (3,640) 3,640  
Proceeds from escrow payment for warrant exercise   29,267  
Payments of deferred offering costs   (85,663)  
Net cash provided by (used in) financing activities   (52,756) 1,190,000
Net change in cash and cash equivalents   (748,449) 1,083,356
Cash and cash equivalents, beginning of period   828,016 204,471
Cash and cash equivalents, end of period $ 79,567 79,567 1,287,827
Supplemental disclosure of non-cash investing and financing activities:      
Accrued interest on subscriptions receivable   231 368
Debt discounts associated with derivative liabilities of convertible promissory notes   37,471 $ 304,000
Deferred offering costs included in accounts payable and accrued expenses   $ 580,636